Sareum Holdings Plc (SAR) - Financial and Strategic SWOT Analysis Review

Date: December 13, 2016
Pages: 46
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S6E9F74395FEN
Leaflet:

Download PDF Leaflet

Sareum Holdings Plc (SAR) - Financial and Strategic SWOT Analysis Review
Sareum Holdings Plc (SAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sareum Holdings Plc (Sareum) is a drug discovery and development company that produces targeted small molecule therapeutics for treating cancer and autoimmune diseases. The company delivers drug candidates for licensing to biotechnology and pharmaceutical companies at the pre-clinical or early clinical trials stage. Its research programs include Chk1 (Checkpoint Kinase 1), Aurora+FLT3 kinase, VEGFR-3 (FLT4) kinase, Fatty Acid Synthase (FASN), Tyrosine kinase 2 (TYK2), ALK Kinase, FLT3 and Microtubule binding agents. Sareum’s Chk1 kinase cancer research program is being conducted through joint research collaboration with Cancer Research Technology Limited and the Institute of Cancer Research. The drug research programs of the company are based on its proprietary drug discovery technology, SKIL (Sareum Kinase Inhibitor Library). Sareum is headquartered in Pampisford Cambridge, the UK.

Sareum Holdings Plc Key Recent Developments

Nov 02, 2016: Sareum Holdings: Final Results
Aug 03, 2016: China and Hong Kong Patent Grants for Sareum's Aurora+FLT3 Kinase Inhibitors
Oct 26, 2015: Sareum Holdings Announcs Final Results For Year Ended 30 June 2015
May 21, 2015: Sareum Launches New Website
Feb 25, 2015: Sareum Holdings Announces Half-Yearly Results For The Six Months Ended 31 December 2014

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Sareum Holdings Plc - Key Facts
    Sareum Holdings Plc - Key Employees
    Sareum Holdings Plc - Key Employee Biographies
    Sareum Holdings Plc - Major Products and Services
    Sareum Holdings Plc - Pharmaceutical Pipeline Products Data
    Sareum Holdings Plc, Pipeline Products by Therapy Area
    Sareum Holdings Plc, Pipeline Products by Development Phase
    Sareum Holdings Plc - History
    Sareum Holdings Plc - Company Statement
    Sareum Holdings Plc - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    Sareum Holdings Plc - Business Description
    Sareum Holdings Plc - Corporate Strategy
    Sareum Holdings Plc - SWOT Analysis
    SWOT Analysis - Overview
    Sareum Holdings Plc - Strengths
    Sareum Holdings Plc - Weaknesses
    Sareum Holdings Plc - Opportunities
    Sareum Holdings Plc - Threats
    Sareum Holdings Plc - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Sareum Holdings Plc, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Nov 02, 2016: Sareum Holdings: Final Results
    Aug 03, 2016: China and Hong Kong Patent Grants for Sareum's Aurora+FLT3 Kinase Inhibitors
    Oct 26, 2015: Sareum Holdings Announcs Final Results For Year Ended 30 June 2015
    May 21, 2015: Sareum Launches New Website
    Feb 25, 2015: Sareum Holdings Announces Half-Yearly Results For The Six Months Ended 31 December 2014
    Jan 20, 2015: Further US Patent Grant for Sareum's Kinase Inhibitors

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Sareum Holdings Plc, Key Facts
    Sareum Holdings Plc, Key Employees
    Sareum Holdings Plc, Key Employee Biographies
    Sareum Holdings Plc, Major Products and Services
    Sareum Holdings Plc, Number of Pipeline Products by Therapy Area
    Sareum Holdings Plc, Number of Pipeline Products by Development Stage
    Sareum Holdings Plc, Pipeline Products By Therapy Area and Development Phase
    Sareum Holdings Plc, History
    Sareum Holdings Plc, Subsidiaries
    Sareum Holdings Plc, Key Competitors
    Sareum Holdings Plc, Ratios based on current share price
    Sareum Holdings Plc, Annual Ratios
    Sareum Holdings Plc, Interim Ratios
    Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Sareum Holdings Plc, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Sareum Holdings Plc, Pipeline Products by Therapy Area
    Sareum Holdings Plc, Pipeline Products by Development Phase
    Sareum Holdings Plc, Performance Chart (2012 - 2016)
    Sareum Holdings Plc, Ratio Charts
    Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Sareum Holdings Plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Sareum Holdings Plc (SAR) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: